Home » Archive by Category

Uncategorized

Bio: Michael Cooke

August 18, 2010 – 8:44 am | Edit Post

Michael P. Cooke received his Ph.D in Biochemistry from the University of Washington, Seattle in 1991 working with Dr. Roger Perlmutter where he studied the role of the src-family kinase, fyn in T cell development …

SDBN August 18th Event: The Human Genome 10 Years Later: What Does it Mean for San Diego Biotech?

July 23, 2010 – 4:31 pm | Edit Post

June 2010 marks the 10th anniversary of the sequencing of the human genome. As Francis Collins has pointed out, “we invariably overestimate the short-term impacts of new technologies and underestimate their longer-term effects.” As a …

#SBS10 Day 3 – Smart mice and blowing House, M.D.’s mind: Drug discovery in epigenetics

April 14, 2010 – 7:37 pm | Edit Post

At the afternoon session of the Society for Biomolecular Science in Phoenix, it’s all about epigenetics, the study of heritable changes that don’t involve changes in genetic sequence. Epigenetics explains why identical twins turn out a little different and why even cloned cows will have different coloration patterns.

SBS Day Two: A Holistic Approach To Drug Discovery #sbs10

April 14, 2010 – 7:11 am | Edit Post

I’m blogging from the Society for Biomolecular Sciences conference in Phoenix, the organizers were kind enough to offer two of us complimentary passes. I was surprised that the sessions were separated into disease area, technique, …

SDBDG BioTalk

September 27, 2009 – 2:16 pm | Edit Post

The Novelix Challenge: Developing Next Generation
Dermatology Drugs in a Low-Cost Virtual Environment
Burkhard Jansen, MD, PhD – CEO
September 30, 2009 5:30 – 8:00 pm (Announcements begin at 6:30 pm)
AT SORRENTO SUMMIT
Meetings are open to everyone and …

SDBN Sept. 22nd Event Featuring Intellikine

September 1, 2009 – 5:08 pm | Edit Post
SDBN Sept. 22nd Event Featuring Intellikine

The September San Diego Biotechnology Network (SDBN) event will feature Intellikine, a leader in the development of innovative, small molecule drugs for the treatment of cancer, inflammation and autoimmune diseases, and recently in the news …

Ali R. Esteghlalian, Ph.D.

August 13, 2009 – 5:53 am | Edit Post

Dr. Ali R. Esteghlalian is a Principal Scientist and Product Manager, Emerging Specialty Enzyme Products at Verenium Corporation (San Diego, California, USA.) He has been involved in enzyme applications research & management, as well as …

The Transformation of the Biotech Business Model: Vote on SDBN’s August Event

July 30, 2009 – 7:06 am | Edit Post

San Diego County biotech in 2008 represented the third largest community for developing the next generation of biopharmaceuticals and cutting edge therapies. The impact of the financial crisis and funding shortfall is accelerating trends set …

test

July 12, 2009 – 7:56 am | Edit Post

twik5z3hxf

Bloggers Wanted!

July 7, 2009 – 6:48 am | Edit Post
Bloggers Wanted!

If you attended the Social Media for Scientists Event we had in May, you know that we are aiming to get more of you involved in the SDBN. One of the ways is through inviting …